HCID 21393464, compound → Hydrochloric Acid
Reaction equation
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[O:11][CH2:10][N:9]3[CH2:12][CH:13]4[C:18](=[O:19])[N:17]([CH3:20])[C:16](=[O:21])[CH:14]4[CH2:15][C:8]3=[N:7][C:6]=2[CH:22]=1>C(Cl)(Cl)Cl>[ClH:1].[ClH:1].[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[O:11][CH2:10][N:9]3[CH2:12][CH:13]4[C:18](=[O:19])[N:17]([CH3:20])[C:16](=[O:21])[CH:14]4[CH2:15][C:8]3=[N:7][C:6]=2[CH:22]=1Participants
4
Reactant 1
Product 2
Reagents, catalysts & solvents 1
Procedure
To 3.40 g of 10-chloro- 3a,4,13,13a-tetrahydro-2-methyl- 1H,6H-pyrrolo[3',4':4,5]pyrido[1,2-c] [1,3,5]benzoxadiazepine-1,3(2H)dione in 25 ml of dry chloroform is added, dropwise, and with external wet ice cooling, 10.0 ml of a 1.05 N ethereal hydrogen chloride solution to obtain the title compound.
Sources & evidence
- ORD record
- ord-0e774185ea4b483b8bec3258fcb53c9b
- Source dataset
- uspto-grants-1977_01
- Patent number
- US04003905
Reaction notes
Loading…